Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin

被引:0
作者
Zhiqiang Song
Wei Fu
Liya Zhou
机构
[1] Peking University Third Hospital,Department of Gastroenterology
来源
BMC Gastroenterology | / 19卷
关键词
Penicillin allergy; Cefuroxime; Levofloxacin; Eradication; Safety; Compliance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 163 条
[21]  
Graham DY(2002)Resistance of helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime J Antimicrob Chemother 49 309-976
[22]  
Macy E(2013)Efficacy of cefixime-based triple therapy for helicobacter pylori eradication: a retrospective study Panminerva Med 55 973-677
[23]  
Mirakian R(1990)Reduction of gastric ulcer recurrence after suppression of helicobacter pylori by cefixime Gut 31 671-18s
[24]  
Leech SC(1996)Cross-reactivity between a penicillin and a cephalosporin with the same side chain J Allergy Clin Immunol 98 13s-377
[25]  
Krishna MT(2007)Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift Diagn Microbiol Infect Dis 57 373-213
[26]  
Richter AG(2013)Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy Helicobacter 18 205-128.e121
[27]  
Huber PA(2013)Sequential versus triple therapy for the first-line treatment of helicobacter pylori: a multicentre, open-label, randomised trial Lancet 381 121-279
[28]  
Farooque S(2013)Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance Gastroenterology 145 274-99
[29]  
Pichichero ME(2013)Antibiotic resistance of helicobacter pylori isolated in the southeast coastal region of China Helicobacter 18 91-639
[30]  
Zagursky R(2016)Tailored versus triple plus bismuth or concomitant therapy as initial helicobacter pylori treatment: a randomized trial Helicobacter 21 634-236